Get the Stockscreener App
1.22
5.01%
0.0582
After Hours:
1.22
Enveric Biosciences Inc stock is traded at $1.22, with a volume of 64,086.
It is up +5.01% in the last 24 hours and down -13.48% over the past month.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
See More
Previous Close:
$1.1618
Open:
$1.18
24h Volume:
64,086
Relative Volume:
0.28
Market Cap:
$3.02M
Revenue:
-
Net Income/Loss:
$-15.08M
P/E Ratio:
-0.19
EPS:
-6.42
Net Cash Flow:
$-11.56M
1W Performance:
+10.91%
1M Performance:
-13.48%
6M Performance:
-10.29%
1Y Performance:
-84.69%
1-Day Range:
$1.17
$1.22
1-Week Range:
$1.08
$1.22
52-Week Range:
$1.01
$8.4465
Enveric Biosciences Inc Stock (ENVB) Company Profile
Name
Enveric Biosciences Inc
Sector
Industry
Phone
239-302-1707
Address
4851 TAMIAMI TRAIL N, SUITE 200, NAPLES
Compare ENVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENVB
Enveric Biosciences Inc
|
1.22 | 2.94M | 0 | -15.08M | -11.56M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Enveric Biosciences Inc Stock (ENVB) Latest News
Will Enveric Biosciences Inc. continue its uptrendJuly 2025 Drop Watch & Free Community Supported Trade Ideas - Newser
Is Enveric Biosciences Inc. showing signs of accumulationJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - Newser
Comparing Enveric Biosciences Inc. in custom built stock radarsJuly 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - Newser
Is This the Dip to Buy in Enveric Biosciences Inc.Treasury Yields & Precise Entry and Exit Recommendations - kangso.co.kr
Should you wait for a breakout in Enveric Biosciences Inc.Earnings Performance Report & Reliable Breakout Forecasts - Newser
Strategies to average down on Enveric Biosciences Inc.2025 Price Targets & Daily Market Momentum Tracking - Newser
Enveric Biosciences Inc. stock trend forecastQuarterly Portfolio Review & Low Risk High Win Rate Picks - Newser
Can you recover from losses in Enveric Biosciences Inc.July 2025 Earnings & Daily Stock Trend Reports - Newser
Will Enveric Biosciences Inc. see short term momentumShort Setup & Real-Time Volume Triggers - Newser
Published on: 2025-08-19 14:54:13 - Newser
Published on: 2025-08-19 04:48:16 - Newser
How Enveric Biosciences Inc. stock performs during market volatilityJuly 2025 Levels & Proven Capital Preservation Tips - Newser
Published on: 2025-08-19 01:52:00 - Newser
Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets - microdose.buzz
Enveric Biosciences Q2 Earnings Miss: Mixed Market Impact and Long-Term Resilience - AInvest
Key resistance and support levels for Enveric Biosciences Inc.Quarterly Investment Review & Low Volatility Stock Suggestions - Newser
Enveric Biosciences Posts Q2 Loss Amid High Operating Costs; Market Reaction Suggests Room for Recovery - AInvest
Published on: 2025-08-17 21:44:18 - Newser
Is Enveric Biosciences Inc. reversing from oversold territoryJuly 2025 Decliners & High Return Stock Watch Alerts - Newser
Is Enveric Biosciences Inc. a speculative investmentStop Loss & Free Fast Entry Momentum Trade Alerts - mustnews.co.kr
Enveric Biosciences Inc. Shows Support at Fibonacci LevelJuly 2025 Price Swings & Long-Term Growth Plans - beatles.ru
How to forecast Enveric Biosciences Inc. trends using time series2025 Trade Ideas & High Conviction Investment Ideas - Newser
Will Enveric Biosciences Inc. stock go up soonTrade Risk Summary & Fast Moving Stock Watchlists - Newser
Is a relief rally coming for Enveric Biosciences Inc. holders2025 Volatility Report & Free Weekly Watchlist of Top Performers - Newser
Earnings visualization tools for Enveric Biosciences Inc.2025 Trading Recap & Long Hold Capital Preservation Tips - Newser
Is Enveric Biosciences Inc. forming a bullish divergenceDip Buying & Weekly High Conviction Ideas - thegnnews.com
Candlestick signals on Enveric Biosciences Inc. stock todayTrade Performance Summary & Long-Term Capital Growth Strategies - Newser
Should you hold or exit Enveric Biosciences Inc. nowQuarterly Profit Summary & Real-Time Buy Zone Alerts - Newser
What MACD signals say about Enveric Biosciences Inc.2025 Volume Leaders & Community Consensus Trade Signals - Newser
Why Enveric Biosciences Inc. stock attracts strong analyst attentionWeekly Trade Summary & Safe Entry Trade Signal Reports - beatles.ru
What is Enveric Biosciences Inc.’s market positionJuly 2025 Summary & Long-Term Safe Investment Ideas - thegnnews.com
How to monitor Enveric Biosciences Inc. with trend dashboardsJuly 2025 Patterns & Real-Time Volume Trigger Notifications - Newser
Is Enveric Biosciences Inc. a Top Dividend Stock to Watch in 2025July 2025 Final Week & Real-Time Volume Spike Alerts - Newser
Published on: 2025-08-15 04:45:53 - Newser
Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results - BioSpace
Traders Consider Averaging Down in Enveric Biosciences Inc.2025 Fundamental Recap & Daily Momentum Trading Reports - metal.it
Enveric Biosciences Reports Q2 FY25 Financial Results, IND-Enabling Progress, Mechanism Confirmation. - AInvest
Published on: 2025-08-14 03:40:59 - Newser
Enveric Biosciences Inc Stock (ENVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):